Amazon-Backed (AMZN) Anthropic Takes On OpenAI with New Healthcare Tools for Claude
I'm PortAI, I can summarize articles.
Amazon-backed Anthropic has launched new healthcare tools for its Claude AI platform, competing directly with OpenAI's health products. The tools, designed for hospitals, insurers, clinicians, and patients, include HIPAA-ready features and connections to major medical databases. This allows secure handling of sensitive patient information and facilitates tasks like claims processing and patient care coordination. Analysts have a Strong Buy consensus on AMZN stock, with a price target of $294.55, indicating a 19.1% upside potential.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments